Both in Biotechnology
Metagenomi Therapeutics vs Elutia
Over the past year MGX returned −67.7% and ELUT returned −21.8%; their daily moves had a correlation of 0.11.
MGX −67.7% ELUT −21.8%Growth of $1, one year, split-adjusted
| Metric | MGX | ELUT |
|---|---|---|
| Price | $0.7308 | $0.7509 |
| Market cap | $27.6M | $33.3M |
| Today | −7.49% | −1.15% |
| 1 month | −25.8% | −8.4% |
| 6 months | −48.5% | −24.8% |
| Year to date | −54.9% | +8.4% |
| 1 year | −68.1% | −18.4% |
| Revenue growth (YoY) | −103.0% | −11.6% |
| Gross margin | — | 59.6% |
| Net margin | — | −315.0% |
| P/E (TTM) | — | 0.6× |
| Price / sales | 2.0× | 2.7× |
| Net cash | $120.7M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 62.2% |
| Short % of float | 5.2% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).